APGE
Apogee Therapeutics, Inc.
135.10$
+0.0%
vs. previous close
Closing price · As of: Sep 3, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 99.3% | 99.6% | 85.2% | 68.9% | 70.3% | 73.0% | 78.5% | 86.3% | 79.1% | 83.0% | 74.2% | |
| 44.2% | 29.5% | 58.9% | 38.4% | 15.3% | 18.8% | 15.0% | 18.9% | 17.2% | 14.0% | 34.9% | 7.9% | |
| 99.2% | 98.5% | 99.1% | 84.5% | 67.8% | 69.1% | 71.9% | 76.8% | 84.2% | 77.9% | 81.9% | 72.8% | |
| – | 0.3% | – | – | 0.6% | 0.6% | 0.7% | 0.6% | 0.7% | 0.6% | 0.6% | – | |
| 4.0% | 5.4% | 2.7% | 3.4% | 5.4% | 4.9% | 5.7% | 5.8% | 6.4% | 3.5% | 2.9% | 10.6% | |
| 4.0% | 5.1% | 2.6% | 3.1% | 4.2% | 3.8% | 4.6% | 4.8% | 5.4% | 3.0% | 2.5% | 2.8% | |
| – | 0.3% | 0.1% | 0.2% | 0.4% | 0.4% | 0.6% | 0.6% | 0.7% | 0.4% | 0.2% | 0.2% | |
| 0.3% | 0.5% | 0.5% | 0.7% | 0.3% | 0.1% | 0.3% | 0.9% | 0.1% | 0.1% | 0.1% | 0.2% | |
| 96.0% | 94.6% | 97.3% | 96.6% | 94.6% | 95.1% | 94.3% | 94.2% | 93.6% | 96.5% | 97.1% | 89.4% | |
| -21.6% | -30.8% | -18.9% | -23.7% | -30.7% | -40.6% | -50.6% | -65.0% | -78.6% | -59.9% | -49.2% | -54.0% | |
| 11.9% | 12.6% | 6.1% | 7.1% | 7.3% | 7.3% | 8.1% | 8.9% | 9.4% | 6.5% | 5.4% | 5.6% |
Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.